JPS6028930A - 人の癌由来細胞の増殖抑制剤の精製方法 - Google Patents

人の癌由来細胞の増殖抑制剤の精製方法

Info

Publication number
JPS6028930A
JPS6028930A JP58136793A JP13679383A JPS6028930A JP S6028930 A JPS6028930 A JP S6028930A JP 58136793 A JP58136793 A JP 58136793A JP 13679383 A JP13679383 A JP 13679383A JP S6028930 A JPS6028930 A JP S6028930A
Authority
JP
Japan
Prior art keywords
medium
malignant tumor
cell
animal
tumor cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58136793A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0361648B2 (https=
Inventor
Tomoyuki Tajima
知行 田島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koken Co Ltd
Original Assignee
Koken Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koken Co Ltd filed Critical Koken Co Ltd
Priority to JP58136793A priority Critical patent/JPS6028930A/ja
Priority to EP84305098A priority patent/EP0133358B1/en
Priority to DE8484305098T priority patent/DE3484410D1/de
Publication of JPS6028930A publication Critical patent/JPS6028930A/ja
Publication of JPH0361648B2 publication Critical patent/JPH0361648B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP58136793A 1983-07-28 1983-07-28 人の癌由来細胞の増殖抑制剤の精製方法 Granted JPS6028930A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP58136793A JPS6028930A (ja) 1983-07-28 1983-07-28 人の癌由来細胞の増殖抑制剤の精製方法
EP84305098A EP0133358B1 (en) 1983-07-28 1984-07-26 Processes for the production of agents for inhibiting the proliferation of malignant tumour cells, and agents produced thereby
DE8484305098T DE3484410D1 (de) 1983-07-28 1984-07-26 Verfahren zur herstellung von die vermehrung von malignen krebszellen hemmenden mitteln, und so erhaltene mittel.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58136793A JPS6028930A (ja) 1983-07-28 1983-07-28 人の癌由来細胞の増殖抑制剤の精製方法

Publications (2)

Publication Number Publication Date
JPS6028930A true JPS6028930A (ja) 1985-02-14
JPH0361648B2 JPH0361648B2 (https=) 1991-09-20

Family

ID=15183643

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58136793A Granted JPS6028930A (ja) 1983-07-28 1983-07-28 人の癌由来細胞の増殖抑制剤の精製方法

Country Status (3)

Country Link
EP (1) EP0133358B1 (https=)
JP (1) JPS6028930A (https=)
DE (1) DE3484410D1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070069A1 (ja) * 2017-10-05 2019-04-11 医療法人社団市川クリニック 殺細胞活性を有する細胞抽出成分又は組成物の調製方法
KR20220144048A (ko) * 2021-04-19 2022-10-26 가천대학교 산학협력단 세포 배양 시 인체 환경적 모사가 가능한 세포 배양 칩

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JPS6028931A (ja) * 1983-07-28 1985-02-14 Koken Kk ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58138383A (ja) * 1982-02-13 1983-08-17 Nippon Shinyaku Co Ltd 生理活性物質の製法
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS59162889A (ja) * 1983-03-07 1984-09-13 Koken Kk 人の悪性腫瘍細胞の増殖抑制剤の製造方法
JPS59204122A (ja) * 1983-05-06 1984-11-19 Koken Kk 人の悪性腫瘍細胞増殖抑制剤の製造方法
JPS6028931A (ja) * 1983-07-28 1985-02-14 Koken Kk ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法
JPS6043386A (ja) * 1983-08-20 1985-03-07 Koken Kk ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の製造方法

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070069A1 (ja) * 2017-10-05 2019-04-11 医療法人社団市川クリニック 殺細胞活性を有する細胞抽出成分又は組成物の調製方法
KR20200044127A (ko) * 2017-10-05 2020-04-28 이료 호진 샤단 이치카와 클리닉 살세포 활성을 가지는 세포 추출 성분 또는 조성물의 조제 방법
CN111201320A (zh) * 2017-10-05 2020-05-26 医疗法人社团市川诊所 具有细胞杀伤活性的细胞提取物成分或组合物的制备方法
US11318162B2 (en) 2017-10-05 2022-05-03 Medical Corporation Ichikawa Clinic Method for preparing cell extract component or composition having cytocidal activity
CN111201320B (zh) * 2017-10-05 2023-09-01 医疗法人社团市川诊所 具有细胞杀伤活性的细胞提取物成分或组合物的制备方法
IL273738B1 (en) * 2017-10-05 2023-10-01 Medical Corp Ichikawa Clinic Method for preparing cell extract component or composition exhibiting cytocidal activity
IL273738B2 (en) * 2017-10-05 2024-02-01 Medical Corp Ichikawa Clinic A method for preparing an ingredient or composition of a cell extract that has cell-killing activity
US11963978B2 (en) 2017-10-05 2024-04-23 Medical Corporation Ichikawa Clinic Method for preparing cell extract component or composition having cytocidal activity
KR20220144048A (ko) * 2021-04-19 2022-10-26 가천대학교 산학협력단 세포 배양 시 인체 환경적 모사가 가능한 세포 배양 칩

Also Published As

Publication number Publication date
JPH0361648B2 (https=) 1991-09-20
EP0133358A2 (en) 1985-02-20
EP0133358B1 (en) 1991-04-10
EP0133358A3 (en) 1986-08-13
DE3484410D1 (de) 1991-05-16

Similar Documents

Publication Publication Date Title
Stockdale et al. 5-Bromodeoxyuridine: effect on myogenesis in vitro
Gulland et al. Phosphoesterases of bone and snake venoms
CN105535022A (zh) 外泌体在制备治疗急性肝衰竭的药物中的用途和药物组合物
WO2008082323A1 (en) Growth stimulating and cell regenerating composition and a method for the production thereof.
JPS6028930A (ja) 人の癌由来細胞の増殖抑制剤の精製方法
Parshley Effect of inhibitors from adult connective tissue on growth of a series of human tumors in vitro
US4595657A (en) Process for preparing an inhibiting agent against proliferation of animals malignant tumor cells
Smith Nutritional Studies on Streptococcus lactis: I. An Unidentified Growth Factor Found in Yeast Extract
CN105193899A (zh) 从柿子中提取总酚的方法
JPH08143462A (ja) 免疫賦活剤及び抗腫瘍剤
WO2001028575A1 (en) Proteoglycan, a bioactive substance from plants
CN117731750A (zh) 一种具有改善微循环及利水祛湿功能的中藏药组合物
CN105218601A (zh) 从柿子中提取单宁的方法
JPS6043386A (ja) ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の製造方法
CN110731977B (zh) 一种柞树皮提取物的制备方法和应用
JPS6028931A (ja) ヒト腎細胞癌由来樹立株細胞の増殖抑制剤の濃縮方法
EP0118286B1 (en) Process for preparing an inhibiting agent
Deshmukh et al. Field resistance to potato blight (Phytophthora infestans)
CN1244691C (zh) 自体胸水上清培养til细胞的方法
DE3485773T2 (de) Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
CN119235949B (zh) 一种具有免疫抑制功能的毛棉杜鹃提取物及其制备方法和应用
CN102764273B (zh) 有尾两栖动物新疆北鲵皮肤分泌物的提纯方法与应用
UA136235U (uk) Спосіб одержання засобу імуномодулюючої дії з трави підмаренника чіпкого
Wolf et al. Initiation of DNA systhesis in mouse 3T3 fibroblasts in response to a specific factor
Vahonina et al. Antioxidant activity of propolis, dead bees and their fractions